Healthcare professionals at Queen's Hospital Burton will be better placed to get patients home safely and as early as possible, whilst freeing up urgently needed capacity, with the help of a technology soon to be deployed.
Following the success of the ExtraMed Patient Flow solution at Royal Derby Hospital, where staff have reduced lengths of stay and enhanced care for patients,
Today, the U.S. Food and Drug Administration cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly a decade.
"Computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality; planning and guiding interventional or therapeutic procedures; and monitoring the effectiveness of certain therapies," said Laurel Burk, Ph.D., assistant director of the Diagnostic X-ray Systems Team in the FDA's Center for Devices and Radiological Health.
Orion Health is supporting the Professional Record Standards Body's partnership scheme by applying to become a 'quality partner'.
The company, which is one of the UK’s leading providers of shared care records and population health management systems, will work with the PRSB to develop the ‘core information standard’ and its assessment process.
Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body). 
Pathologists at one of England's most innovative trusts have chosen the CliniSys laboratory information system (LIMS) as part of a digital strategy to support its drive to continually improve patient care.
The pathology team at Northumbria Healthcare NHS Foundation Trust has decided to replace their legacy LIMS with WinPath Enterprise, hosted by CliniSys from its UK data centre.
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.